| Line Item | 2024-06-30 | Y/Y |
|---|---|---|
| Revenue | $6.12B | +10.2% |
| Cost of Revenue | $2.18B | +8.6% |
| Gross Profit | $3.94B | +11.0% |
| R&D Expense | $126.8M | +20.5% |
| SG&A Expense | $3.16B | +12.2% |
| Operating Income | $546.7M | +0.6% |
| Pre-tax Income | $204.5M | -71.0% |
| Income Tax | $95.1M | -47.6% |
| Net Income | $89.4M |
| Line Item | 2024-06-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $300.8M | +21.8% |
| Accounts Receivable | $441.6M | +22.4% |
| Inventory | $764.1M | -10.5% |
| Current Assets | $1.96B | -4.3% |
| Total Assets | $12.08B | -4.6% |
| Current Liabilities | $2.60B | -4.9% |
| Long-term Debt | $3.84B | -8.1% |
| Line Item | 2024-06-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | $614.6M | -1.8% |
| Investing Cash Flow | -$226.2M | -91.4% |
| Financing Cash Flow | -$336.7M | +28.3% |
| -82.4% |
| EPS (Basic) | $0.09 | -84.5% |
| EPS (Diluted) | $0.09 | -84.2% |
| Total Liabilities |
| $7.83B |
| -7.0% |
| Stockholders' Equity | $3.83B | +0.4% |